Improving health behaviors and outcomes after angioplasty: using economic theory to inform intervention

被引:19
|
作者
Charlson, ME
Allegrante, JP [1 ]
McKinley, PS
Peterson, JC
Boutin-Foster, C
Ogedegbe, G
Young, CR
机构
[1] Columbia Univ, Teachers Coll, Natl Ctr Hlth Educ, New York, NY 10027 USA
[2] Columbia Univ, Teachers Coll, Dept Hlth & Behav Studies, New York, NY 10027 USA
[3] Cornell Univ, Weill Med Coll, Div Gen Internal Med, New York, NY 10021 USA
[4] Cornell Univ, Weill Med Coll, Ctr Complementary & Integrat Med, New York, NY 10021 USA
[5] Columbia Presbyterian Med Ctr, Behav Med Program, New York, NY 10032 USA
关键词
D O I
10.1093/her/17.5.606
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Patients who have been relieved of cardiac symptoms following angioplasty may not be sufficiently motivated to initiate behavior changes that can reduce risk of subsequent cardiac events. Finding an effective means to help patients modify their behavior thus presents a unique challenge. This paper describes an innovative behavioral intervention whose theoretical underpinning is net-present value economic theory. This intervention is being evaluated in a randomized controlled trial in which all patients complete a computerized baseline health assessment of 14 cardiovascular risk factors. Each patient is presented with an individualized risk-factor profile and asked to choose risk factors for modification. In the experimental group, each risk factor is presented with a corresponding numerical biologic age value that represents the relative potential to benefit from modifying each risk factor. Risk reduction for these patients is framed as the opportunity to reduce present biologic age (the net-present value), and improve current health status and quality of life. In the control group, risk reduction is framed in the standard risk-factor approach as the value of preventing future health problems. We hope to demonstrate that economic theory is a plausible perspective from which to design interventions aimed at communicating risk and facilitating change in health behaviors.
引用
收藏
页码:606 / 618
页数:13
相关论文
共 50 条
  • [41] Improving the state of health programming by using diffusion theory
    Dearing, JW
    [J]. JOURNAL OF HEALTH COMMUNICATION, 2004, 9 : 21 - 36
  • [42] Improving outcomes after cardiac arrest using NO inhalation
    Ichinose, Fumito
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2013, 23 (02) : 52 - 58
  • [43] MECHANISMS WITHIN ROMANTIC RELATIONSHIPS THAT IMPACT HEALTH BEHAVIORS AND OUTCOMES: IDENTIFYING INTERVENTION TARGETS
    Ranby, Krista
    Wooldridge, Jennalee
    vanDellen, Michelle
    Lewis, Megan
    Varner, Sydneyjane
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S1614 - S1614
  • [44] Economic outcomes after coronary stenting or balloon angioplasty in the Benestent II trial: The US perspective
    Cohen, DJ
    vanHoute, B
    Juliard, JMJ
    Nelson, GI
    Morice, MC
    Penn, IM
    Bonzel, T
    Gey, JJ
    Hadjimiltiades, S
    Bourdonnec, C
    Simon, R
    Serruys, PW
    [J]. CIRCULATION, 1997, 96 (08) : 2547 - 2547
  • [45] Improving cardiovascular health behaviors through a comprehensive lifestyle intervention program during the pandemic in India
    Chockalingam, P.
    Rajeswari, S.
    Shobika, J.
    Anantharaman, R.
    Yusuf, M. M.
    Sengottuvelu, G.
    Chockalingam, V.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 : 131 - 132
  • [46] Economic outcomes after rotational ablation or balloon angioplasty: Results from the randomized DART trial
    Seto, TB
    Taira, DA
    Berezin, RH
    Cohen, DJ
    [J]. CIRCULATION, 1998, 98 (17) : 412 - 412
  • [47] Evaluation of a Person-Centered, Theory-Based Intervention to Promote Health Behaviors
    Worawong, Chiraporn
    Borden, Mary Jo
    Cooper, Karen M.
    Perez, Oscar A.
    Lauver, Diane
    [J]. NURSING RESEARCH, 2018, 67 (01) : 6 - 15
  • [48] Using Health Outcomes Data to Inform Decision-MakingA Pharmaceutical Industry Perspective
    Martin Keech
    [J]. PharmacoEconomics, 2001, 19 : 27 - 31
  • [49] Using health outcomes data to inform decision-making - Healthcare payer perspective
    Lancry, PJ
    O'Connor, R
    Stempel, D
    Raz, M
    [J]. PHARMACOECONOMICS, 2001, 19 (Suppl 2) : 39 - 47
  • [50] Using health outcomes data to inform decision-making - A pharmaceutical industry perspective
    Keech, M
    [J]. PHARMACOECONOMICS, 2001, 19 (Suppl 2) : 27 - 31